Heart Disease News and Research

Latest Heart Disease News and Research

Ghana rolls out vaccines against pneumonia and diarrhoea

Ghana has become the first African country to introduce pneumococcal and rotavirus vaccines at the same time, simultaneously tackling the leading causes of the world’s two biggest childhood killers – pneumonia and diarrhoea.

26 Apr 2012

Diabetes alone may cost a sixth of total NHS budget by 2035: Report

A new report warns that diabetes will cost the NHS more than a sixth of its entire budget by 2035. The disease accounts for 10 per cent (£9.8 billion) of NHS spending, but this is projected to rise to £16.9 billion over the next 25 years, or 17 per cent of the health service's funds. There are around 3.8 million people living with diabetes in the UK and this is expected to increase to 6.25 million in just over two decades.

26 Apr 2012

Aspirin reduces bowel cancer death and lung cancer incidence: Research suggests

There is previous evidence suggesting aspirin might prevent certain cancers from developing in the first place. And more recent work suggests it might also work as a cancer therapy - slowing down or preventing a cancer's spread. But the drug can also have unpleasant and dangerous side effects, causing irritation of the stomach lining and internal bleeds in a very small minority of patients.

26 Apr 2012

Great Lakes NeuroTechnologies secures funding for development and testing of innovative neurotechnology

Great Lakes NeuroTechnologies Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson's Disease and Neuroscience Education April 24, 2012: Valley View, OH - Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of Health's SBIR program. Each project is focused on developing and testing innovative neurotechnology. Two projects focus on the monitoring and treatment of Parkinson's disease while another will develop a wireless physiological monitor and web-based teaching system for high school neuroscience courses.

26 Apr 2012

Pervasive racial bias in medical practice adversely affects treatment and diagnosis

Pervasive racial bias in American medical practice adversely affects treatment and diagnosis for African American patients, according to new research from The University of Texas at Austin.

26 Apr 2012

Brain scans of small group of people can predict actions of entire populations

Brain scans of a small group of people can predict the actions of entire populations, according to a new study by researchers from the University of Michigan, the University of Oregon and the University of California at Los Angeles.

26 Apr 2012

Helpful roles of rank, toxic substances

Usually, we think of mold, feces, nitric oxide, hydrogen sulfide and rat poison as rank, toxic or both. But scientists funded by the National Institutes of Health are learning more about the helpful roles these substances can play.

26 Apr 2012

Fatter children more likely to develop cardiometabolic disease, hypertension

A new study from presented at the European Society of Hypertension conference in London shows that children who show greater adiposity (fatness) in early life are at a substantially increased risk for hypertension and cardiometabolic problems in later life.

26 Apr 2012

Cardiovascular emergencies may benefit from regionalized systems of care

Experts are proposing a new model of care collaboration to diagnosis, treat and follow patients who present with various emergent cardiovascular conditions which require rapid, resource-intensive care and confer a high risk of mortality, in an article published April 24 in Circulation.

26 Apr 2012

First-ever study to evaluate effects of interaction between metamphetamines and Ibudilast

John W. Tsuang, M.D., principal investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), in conjunction with Steven J. Shoptaw, Ph.D., from the UCLA Department of Family Medicine, is spearheading a Phase I clinical safety trial that for the first time examines the effects of Ibudilast when administered with metamphetamine (MA), an addictive stimulant that is closely related to amphetamine.

26 Apr 2012

Scientists identify linchpin of fat metabolism

Humans are built to hunger for fat, packing it on during times of feast and burning it during periods of famine. But when deluged by foods rich in fat and sugar, the modern waistline often far exceeds the need to store energy for lean times, and the result has been an epidemic of diabetes, heart disease and other obesity-related problems.

26 Apr 2012

Physical activity reduces oxidative stress in people with SCT

Sickle cell disease (SCD), an inherited condition that causes red blood cells to sometimes deform into a crescent shape, affects an estimated 100,000 Americans, typically those of African descent. However, far more have sickle cell trait (SCT), caused when individuals carry just a single copy of the disease-causing mutation in their genes.

26 Apr 2012

UW researcher receives Dr. Harry L. Galanty Young Investigator Award

University of Washington researcher Jessie Fudge, MD received the Dr. Harry L. Galanty Young Investigator's Award for excellence in sports medicine research at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, Ga. on April 24, 2012.

26 Apr 2012

FDA issues complete response letter to Takeda’s NDAs for type 2 diabetes investigational therapies

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc. today announced that the company received a complete response letter from the United States (U.S.) Food and Drug Administration (FDA) regarding New Drug Applications (NDAs) for alogliptin and fixed-dose combination (FDC) alogliptin and pioglitazone.

26 Apr 2012

Kv7.4 channels may play a fundamental role in high blood pressure

Scientists have identified what could be a biological tipping point in the development of high blood pressure, in a discovery that could one day lead to new treatment.

26 Apr 2012

EuroPRevent2012 to take place from May 3-5 in Dublin

EuroPRevent2012, the premier European event on cardiovascular disease (CVD) prevention, brings together the latest guidelines and studies focused on reducing the global epidemic of heart disease.

26 Apr 2012

Link between obesity and RA in women

Obesity and the painful autoimmune disorder rheumatoid arthritis are each becoming more common, raising a logical question: Could one have something to do with the other? For women, it appears there is a link, Mayo Clinic researchers say.

26 Apr 2012

Strong light can treat myocardial infarction

There are lots of ways to treat a heart attack - CPR, aspirin, clot-busters and more. Now CU medical school researchers have found a new candidate: Intense light.

26 Apr 2012

Body’s own DNA can cause inflammation in the heart

DNA from the heart's own cells plays a role in heart failure by mistakenly activating the body's immune system, according to a study by British and Japanese researchers, co-funded by the British Heart Foundation.

26 Apr 2012

FDA approves Spectranetics' advanced GlideLight Laser Sheath

The Spectranetics Corporation today announced FDA approval of the new advanced GlideLight Laser Sheath for removal of cardiac leads. As part of the company's vision to safely manage every lead, GlideLight delivers more precise control to reduce the force for safe lead extraction.

26 Apr 2012